CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea
· Delayed Price · Currency is KRW 11,360
-90 (-0.79%)
Last updated: Mar 25, 2025
CJ Bioscience Revenue
In the year 2024, CJ Bioscience had annual revenue of 3.47B KRW, down -37.82%. CJ Bioscience had revenue of 941.25M in the quarter ending December 31, 2024, a decrease of -34.71%.
Revenue
3.47B
Revenue Growth
-37.82%
P/S Ratio
27.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
131.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.47B | -2.11B | -37.82% |
| Dec 31, 2023 | 5.58B | 1.50B | 36.82% |
| Dec 31, 2022 | 4.07B | -288.37M | -6.61% |
| Dec 31, 2021 | 4.36B | -948.52M | -17.86% |
| Dec 31, 2020 | 5.31B | 528.32M | 11.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |